Asia Raises Bar for New Drugs, Manufacturers With Tougher CMC Reviews, GMP Inspections - A Look At China (Part 4)

China's pharmaceutical regulatory system is in flux as it grows with the emerging economic giant's rapidly expanding drug manufacturing sector

More from Archive

More from Scrip